Research Article

Clinical significance of fascin-1 and laminin-5 in non-small cell lung cancer.

Published: December 31, 1969
Genet. Mol. Res. 16(2): gmr16029617 DOI: https://doi.org/10.4238/gmr16029617
Cite this Article:
(2017). Clinical significance of fascin-1 and laminin-5 in non-small cell lung cancer.. Genet. Mol. Res. 16(2): gmr16029617. https://doi.org/10.4238/gmr16029617
1,110 views

Abstract

Lung cancer is the leading cause of cancer death in men and the second leading cause of cancer death in women worldwide. Fascin-1 and laminin-5 were associated with the invasiveness and prognoses of several cancers. The expression and the serum levels of fascin-1 and laminin-5 in patients with non-small cell lung cancer (NSCLC) were analyzed in this study. The expression of fascin-1 and laminin-5 were examined in 378 patients and their serum level was measured in 154 patients. The health of all patients was followed post-surgery. The expression of fascin-1 (P = 0.000) and lanminin-5 (P = 0.001) and the serum levels of fascin-1 (P = 0.015) and laminin-5 (P = 0.046) were related to the relapse of patients with NSCLC. Both serum levels and expression of fascin-1 and laminin-5 can be used to effectively evaluate the prognoses of patients with NSCLC.

Download: